Abbott India Limited vs Birlasoft Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Birlasoft Limited (Information technology services and consulting) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Choose Abbott India Limited if you want exposure to a branded pharmaceutical business with established doctor and pharmacy distribution, stronger parentage, and a focus on chronic and specialty therapies. Choose Birlasoft Limited if you prefer an IT services and consulting business with enterprise platform capabilities, global delivery, and vertical expertise across manufacturing, BFSI, life sciences, and energy. The right choice depends on whether the buyer prioritizes pharma market exposure and branded formulations, or technology services with broader enterprise and sector reach.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Birlasoft Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately INR 5,200-5,400 crore, unverified rough range | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately INR 600-650 crore, unverified rough range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Birlasoft Limited
Information technology services and consulting · India
Birlasoft Limited is an India-based IT services and consulting company and part of the CK Birla Group. It provides digital transformation, enterprise application, cloud, data, AI, and managed services to clients across sectors such as manufacturing, banking, insurance, life sciences, energy, and utilities.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage through the CK Birla Group
- Established capabilities in enterprise platforms such as SAP, Oracle, Microsoft, and Salesforce
- Global delivery model with India-based cost advantages
- Focused vertical expertise in manufacturing, BFSI, life sciences, and energy
Weaknesses
- Smaller scale compared with top-tier Indian IT services companies
- Revenue concentration risk if dependent on large enterprise clients
- Lower brand visibility than larger global consulting and technology firms
- Exposure to pricing pressure in commoditized IT services
Opportunities
- Rising demand for cloud migration, AI adoption, and data modernization
- Expansion of managed services and recurring revenue contracts
- Growth in enterprise platform modernization across SAP, Oracle, Microsoft, and Salesforce ecosystems
- Cross-selling digital services to existing large accounts
Threats
- Intense competition from larger IT services firms and global consultancies
- Slowdown in discretionary technology spending by enterprise clients
- Talent retention and wage inflation in the IT services sector
- Currency volatility affecting margins and reported results
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Birlasoft Limited: which company leads overall?
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Embedded Finance & Banking-as-a-Service (BaaS) Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
India Protein Industry Outlook — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Birlasoft Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is a listed Indian pharmaceutical subsidiary of Abbott Laboratories focused on branded prescription and over-the-counter healthcare products.
- Abbott India Limited operates across therapeutic areas including gastroenterology, women’s health, metabolic disorders, central nervous system, pain management, and vaccines.
- Birlasoft Limited is an India-based IT services and consulting company and part of the CK Birla Group.
- Birlasoft Limited delivers digital transformation, enterprise application, cloud, data, AI, and managed services across sectors including manufacturing, banking, insurance, life sciences, energy, and utilities.